Risk Factors for Diabetic Retinopathy in Chinese Patients with Different Diabetes Duration: Association of C-Peptide and BUN/Cr Ratio with Type 2 Diabetic Retinopathy

Background and Aim Controlling the risk factors was the most effective strategy to prevent diabetic retinopathy (DR). This study aimed to recognize the risk factors of DR, and explores whether the effect of those factors is modified by diabetes mellitus (DM) duration. Methods A total of 1058 DM patients with information about DR assessment were included. DR was measured by a complete ophthalmic examination and was classified as having one or more distinct microaneurysms in the eyes. Data from the lab and clinical factors were gathered. Multivariate logistic analysis was used to examine the risk factors, and the best-fitting model was selected by a backward stepwise based on A1C. Results In the current study, 274 (25.9%) patients developed DR. In the entire subjects, baseline age, the level of C-peptide, and urinary creatinine were all presented as protective effects of DR, whose odds ratios (ORs) and 95% confidence intervals (CIs) were 0.79 (0.62, 0.99), 0.75 (0.61, 0.91), and 0.70 (0.52, 0.93), respectively. Conversely, systolic pressure (SBP), urinary albumin, and BUN/Cr ratio were the important risk factors for DR with ORs (95% CIs) 1.21 (1.01, 1.46), 1.55 (1.30, 1.84), and 1.33 (1.11, 1.59), respectively. In stratification analysis, females with higher SBP would be more likely to develop DR in the short-duration group, while C-peptide and urinary creatinine showed protective effects in the long-duration group. BUN/Cr ratio all presented as a risk factor, with ORs 1.38 (p = 0.041) and 1.33 (p = 0.014) in short- and long-duration groups, respectively. Conclusion Although renal functions presented a significant association with DR in all DM patients, the risk factors of DR varied widely in different disease-duration subjects. Target strategies to prevent DR should be put forward individually, considering the patient’s DM duration. Improving the BUN/Cr ratio may be beneficial to delaying DR.

[1]  Yu-Ming Niu,et al.  Association between Transcription Factor 7-Like 2 C/T Polymorphism and Diabetic Retinopathy Risk: A Meta-Analysis , 2022, Ophthalmic Research.

[2]  J. Stewart,et al.  Male sex increases the risk of diabetic retinopathy in an urban safety-net hospital population without impacting the relationship between axial length and retinopathy , 2022, Scientific Reports.

[3]  H. Hashemi,et al.  High prevalence of diabetes in elderly of Iran: an urgent public health issue , 2022, Journal of Diabetes & Metabolic Disorders.

[4]  S. Pardhan,et al.  Associations between diabetic retinopathy and modifiable risk factors: An umbrella review of meta‐analyses , 2022, Diabetic medicine : a journal of the British Diabetic Association.

[5]  S. Sivaprasad,et al.  Prevalence and risk factors for diabetic retinopathy in prediabetes in Asian Indians. , 2022, Journal of diabetes and its complications.

[6]  Jonathan S. Chang,et al.  Management of Complications and Vision Loss from Proliferative Diabetic Retinopathy , 2021, Current Diabetes Reports.

[7]  Lina Lu,et al.  Prevalence and risk factors of diabetic retinopathy in patients with type 2 diabetes in Shanghai. , 2021, International journal of ophthalmology.

[8]  C. Wykoff,et al.  Risk of Blindness Among Patients With Diabetes and Newly Diagnosed Diabetic Retinopathy , 2021, Diabetes Care.

[9]  Yunxian Yu,et al.  Anemia and Diabetic Kidney Disease Had Joint Effect on Diabetic Retinopathy Among Patients With Type 2 Diabetes , 2020, Investigative ophthalmology & visual science.

[10]  Y. Liu,et al.  Associations of serum uric acid and urinary albumin with the severity of diabetic retinopathy in individuals with type 2 diabetes , 2020, BMC Ophthalmology.

[11]  J. Ludvigsson,et al.  LDL cholesterol level as a risk factor for retinopathy and nephropathy in children and adults with type 1 diabetes mellitus: A nationwide cohort study , 2020, Journal of internal medicine.

[12]  D. Friedman,et al.  Diabetic Retinopathy, Visual Impairment, and the Risk of Six-Year Death: A Cohort Study of a Rural Population in China , 2020, Ophthalmic Research.

[13]  V. Rigalleau,et al.  Relationship Between Diabetic Retinopathy Stages and Risk of Major Lower-Extremity Arterial Disease in Patients With Type 2 Diabetes , 2020, Diabetes Care.

[14]  Chen Chen,et al.  Associations between alcohol intake and diabetic retinopathy risk: a systematic review and meta-analysis , 2020, BMC Endocrine Disorders.

[15]  R. Mastropasqua,et al.  PHOTORECEPTOR DAMAGE IN DIABETIC CHOROIDOPATHY. , 2020, Retina.

[16]  J. Chae,et al.  Relationship between Clinical Features of Diabetic Retinopathy and Systemic Factors in Patients with Newly Diagnosed Type II Diabetes Mellitus , 2020, Journal of Korean medical science.

[17]  Dong Li,et al.  Prevalence of and Risk Factors for Diabetic Retinopathy and Diabetic Macular Edema in Patients with Early- and Late-Onset Diabetes Mellitus , 2020, Ophthalmic Research.

[18]  P. Yılmazbaş,et al.  Effects of diabetes duration and HgA1C level on corneal endothelial morphology , 2020, European journal of ophthalmology.

[19]  Wenhui Jiang,et al.  Establishment and Validation of a Risk Prediction Model for Early Diabetic Kidney Disease Based on a Systematic Review and Meta-Analysis of 20 Cohorts , 2020, Diabetes Care.

[20]  T. Wong,et al.  Hypertension, blood pressure control and diabetic retinopathy in a large population-based study , 2020, PloS one.

[21]  Stephen J. Aldington,et al.  Screening for diabetic retinopathy: new perspectives and challenges. , 2020, The lancet. Diabetes & endocrinology.

[22]  T. Bek.  Incidence and Risk for Developing Proliferative Diabetic Retinopathy after Photocoagulation for Diabetic Maculopathy , 2020, Current eye research.

[23]  Y. Liao,et al.  Clinical Features and Microvascular Complications Risk Factors of Early-onset Type 2 Diabetes Mellitus , 2019, Current Medical Science.

[24]  Jennifer I. Lim,et al.  Diabetic Retinopathy Preferred Practice Pattern®. , 2019, Ophthalmology.

[25]  Li-min Liu,et al.  Diabetic Optic Neuropathy and Its Risk Factors in Chinese Patients With Diabetic Retinopathy. , 2019, Investigative ophthalmology & visual science.

[26]  Xiaodan Jiang,et al.  Risk factors of diabetic retinopathy and sight-threatening diabetic retinopathy: a cross-sectional study of 13 473 patients with type 2 diabetes mellitus in mainland China , 2017, BMJ Open.

[27]  H. Chen,et al.  Prevalence and risk factors for diabetic retinopathy in China: a multi-hospital-based cross-sectional study , 2017, British Journal of Ophthalmology.

[28]  H. Y. Lin,et al.  Diabetic Retinopathy and Clinical Parameters Favoring the Presence of Diabetic Nephropathy could Predict Renal Outcome in Patients with Diabetic Kidney Disease , 2017, Scientific Reports.

[29]  S. McGhee,et al.  Diabetic retinopathy screening: global and local perspective. , 2016, Hong Kong medical journal = Xianggang yi xue za zhi.

[30]  D. Ting,et al.  Diabetic retinopathy: global prevalence, major risk factors, screening practices and public health challenges: a review , 2016, Clinical & experimental ophthalmology.

[31]  Y. Park,et al.  The Association between Chronic Kidney Disease and Diabetic Retinopathy: The Korea National Health and Nutrition Examination Survey 2008-2010 , 2015, PloS one.

[32]  K. Ha,et al.  C-peptide replacement therapy as an emerging strategy for preventing diabetic vasculopathy. , 2014, Cardiovascular research.

[33]  José Cunha-Vaz,et al.  Phenotypes and biomarkers of diabetic retinopathy , 2014, Progress in Retinal and Eye Research.

[34]  Ebenezer Daniel,et al.  Association between retinopathy and cardiovascular disease in patients with chronic kidney disease (from the Chronic Renal Insufficiency Cohort [CRIC] Study). , 2012, The American journal of cardiology.

[35]  K. Xiang,et al.  Determination of diabetic retinopathy prevalence and associated risk factors in Chinese diabetic and pre‐diabetic subjects: Shanghai diabetic complications study , 2012, Diabetes/metabolism research and reviews.

[36]  B. Klein,et al.  Global Prevalence and Major Risk Factors of Diabetic Retinopathy , 2012, Diabetes Care.

[37]  Liang Xu,et al.  PREVALENCE AND RISK FACTORS FOR DIABETIC RETINOPATHY: The Beijing Communities Diabetes Study 6 , 2012, Retina.

[38]  J. Shaw,et al.  IDF Diabetes Atlas: Global estimates for the prevalence of diabetes for 2015 and 2040. , 2011, Diabetes research and clinical practice.

[39]  D. Friedman,et al.  Risk factors for diabetic retinopathy in a rural Chinese population with type 2 diabetes: the Handan Eye Study , 2011, Acta ophthalmologica.

[40]  H. Kwon,et al.  Diabetic retinopathy is associated with subclinical atherosclerosis in newly diagnosed type 2 diabetes mellitus. , 2011, Diabetes research and clinical practice.

[41]  Michael Brownlee,et al.  Diabetic Retinopathy: Targeting Vasoregression , 2011, Diabetes.

[42]  Ann L. Albright,et al.  Prevalence of diabetic retinopathy in the United States, 2005-2008. , 2010, JAMA.

[43]  B. Ainsworth,et al.  International physical activity questionnaire: 12-country reliability and validity. , 2003, Medicine and science in sports and exercise.

[44]  Nathan Congdon,et al.  The Prevalence of Diabetic Retinopathy in the United States , 2002 .

[45]  J. Rotter,et al.  Challenges in elucidating the genetics of diabetic retinopathy. , 2014, JAMA ophthalmology.